ArticleBMC anesthesiology2025
Improving renal transplant outcomes through the tubeless anesthesia technique in renal transplantation: a retrospective study.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the feasibility and benefits of tubeless anesthesia (TA), using a laryngeal mask airway instead of endotracheal intubation (ETT), in renal transplantation, aligning with tubeless surgery principles.
methodsA single-center, retrospective matched-cohort study compared perioperative outcomes and 90-day graft function between TA and ETT in kidney transplantation. 52 adult recipients (26 TA, 26 ETT) operated between July-December 2024 were included. Groups were balanced for age, BMI, ASA classification, and dialysis duration. The Mann-Whitney U test and T test (SPSS 22.0) were used to analyze the outcome indicators: intraoperative anesthetic management, hemodynamics, recovery parameters, and graft function.
resultsThe TA group required significantly lower median doses of cisatracurium (12.6 mg vs. 26.1 mg; p < 0.001) and sufentanil (22.3 µg vs. 28.7 µg; p = 0.026). Operative times were similar (211.5 min vs. 200.8 min; p = 0.475). Vasoactive agent use was lower in the TA group (53.8% vs. 73.1%; p = 0.211), with fewer requiring dual agents (3.8% vs. 15.4%). TA patients exhibited faster awakening (recovery time: 18.5 min vs. 34.4 min; p < 0.001) and fewer airway complications (7.7% vs. 26.9%; p = 0.070). At 90 days, the TA group had significantly lower serum creatinine (105.6 µmol/L vs. 142.6 µmol/L; p = 0.015). Delayed graft function (15.4% vs. 11.5%; p = 1.000) and early postoperative renal function did not differ significantly.
conclusionTubeless anesthesia offers perioperative advantages and early graft function benefits in renal transplantation, reducing opioid/muscle relaxant requirements and accelerating recovery. Prospective large-scale studies are warranted to confirm its role in optimizing transplant outcomes.
trial registrationThis study is a retrospective study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.